A citation-based method for searching scientific literature

Jessica L Mega, Tabassome Simon, Jean-Philippe Collet, Jeffrey L Anderson, Elliott M Antman, Kevin Bliden, Christopher P Cannon, Nicolas Danchin, Betti Giusti, Paul Gurbel, Benjamin D Horne, Jean-Sebastian Hulot, Adnan Kastrati, Gilles Montalescot, Franz-Josef Neumann, Lei Shen, Dirk Sibbing, P Gabriel Steg, Dietmar Trenk, Stephen D Wiviott, Marc S Sabatine. JAMA 2010
Times Cited: 728







List of co-cited articles
585 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update.
S A Scott, K Sangkuhl, C M Stein, J-S Hulot, J L Mega, D M Roden, T E Klein, M S Sabatine, J A Johnson, A R Shuldiner. Clin Pharmacol Ther 2013
555
42

A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI.
Daniel M F Claassens, Gerrit J A Vos, Thomas O Bergmeijer, Renicus S Hermanides, Arnoud W J van 't Hof, Pim van der Harst, Emanuele Barbato, Carmine Morisco, Richard M Tjon Joe Gin, Folkert W Asselbergs,[...]. N Engl J Med 2019
182
42

Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy.
Alan R Shuldiner, Jeffrey R O'Connell, Kevin P Bliden, Amish Gandhi, Kathleen Ryan, Richard B Horenstein, Coleen M Damcott, Ruth Pakyz, Udaya S Tantry, Quince Gibson,[...]. JAMA 2009
35

Cytochrome p-450 polymorphisms and response to clopidogrel.
Jessica L Mega, Sandra L Close, Stephen D Wiviott, Lei Shen, Richard D Hockett, John T Brandt, Joseph R Walker, Elliott M Antman, William Macias, Eugene Braunwald,[...]. N Engl J Med 2009
33

Ticagrelor versus clopidogrel in patients with acute coronary syndromes.
Lars Wallentin, Richard C Becker, Andrzej Budaj, Christopher P Cannon, Håkan Emanuelsson, Claes Held, Jay Horrow, Steen Husted, Stefan James, Hugo Katus,[...]. N Engl J Med 2009
33

Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.
Larisa H Cavallari, Craig R Lee, Amber L Beitelshees, Rhonda M Cooper-DeHoff, Julio D Duarte, Deepak Voora, Stephen E Kimmel, Caitrin W McDonough, Yan Gong, Chintan V Dave,[...]. JACC Cardiovasc Interv 2018
142
30

Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial.
Lars Wallentin, Stefan James, Robert F Storey, Martin Armstrong, Bryan J Barratt, Jay Horrow, Steen Husted, Hugo Katus, P Gabriel Steg, Svati H Shah,[...]. Lancet 2010
553
28

Prasugrel versus clopidogrel in patients with acute coronary syndromes.
Stephen D Wiviott, Eugene Braunwald, Carolyn H McCabe, Gilles Montalescot, Witold Ruzyllo, Shmuel Gottlieb, Franz-Joseph Neumann, Diego Ardissino, Stefano De Servi, Sabina A Murphy,[...]. N Engl J Med 2007
28

Genetic determinants of response to clopidogrel and cardiovascular events.
Tabassome Simon, Céline Verstuyft, Murielle Mary-Krause, Lina Quteineh, Elodie Drouet, Nicolas Méneveau, P Gabriel Steg, Jean Ferrières, Nicolas Danchin, Laurent Becquemont. N Engl J Med 2009
23

Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention: The TAILOR-PCI Randomized Clinical Trial.
Naveen L Pereira, Michael E Farkouh, Derek So, Ryan Lennon, Nancy Geller, Verghese Mathew, Malcolm Bell, Jang-Ho Bae, Myung Ho Jeong, Ivan Chavez,[...]. JAMA 2020
84
27

Pharmacogenomic Approach to Selecting Antiplatelet Therapy in Patients With Acute Coronary Syndromes: The PHARMCLO Trial.
Francesca Maria Notarangelo, Giuseppe Maglietta, Paola Bevilacqua, Marco Cereda, Piera Angelica Merlini, Giovanni Quinto Villani, Paolo Moruzzi, Giampiero Patrizi, Guidantonio Malagoli Tagliazucchi, Antonio Crocamo,[...]. J Am Coll Cardiol 2018
86
25

Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial.
Jason D Roberts, George A Wells, Michel R Le May, Marino Labinaz, Chris Glover, Michael Froeschl, Alexander Dick, Jean-Francois Marquis, Edward O'Brien, Sandro Goncalves,[...]. Lancet 2012
266
19

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Glenn N Levine, Eric R Bates, John A Bittl, Ralph G Brindis, Stephan D Fihn, Lee A Fleisher, Christopher B Granger, Richard A Lange, Michael J Mack, Laura Mauri,[...]. J Am Coll Cardiol 2016
760
18

Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention.
Dirk Sibbing, Daniel Aradi, Dimitrios Alexopoulos, Jurrien Ten Berg, Deepak L Bhatt, Laurent Bonello, Jean-Philippe Collet, Thomas Cuisset, Francesco Franchi, Lisa Gross,[...]. JACC Cardiovasc Interv 2019
172
17


Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial.
Dirk Sibbing, Dániel Aradi, Claudius Jacobshagen, Lisa Gross, Dietmar Trenk, Tobias Geisler, Martin Orban, Martin Hadamitzky, Béla Merkely, Róbert Gábor Kiss,[...]. Lancet 2017
242
14

Clinical Outcomes and Sustainability of Using CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.
Craig R Lee, Vindhya B Sriramoju, Alexandra Cervantes, Lucius A Howell, Nicholas Varunok, Shivanshu Madan, Kasey Hamrick, Melissa J Polasek, John Andrew Lee, Megan Clarke,[...]. Circ Genom Precis Med 2018
39
35

Multisite Investigation of Strategies for the Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy.
Philip E Empey, James M Stevenson, Sony Tuteja, Kristin W Weitzel, Dominick J Angiolillo, Amber L Beitelshees, James C Coons, Julio D Duarte, Francesco Franchi, Linda J B Jeng,[...]. Clin Pharmacol Ther 2018
61
21

Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes.
Jessica L Mega, Sandra L Close, Stephen D Wiviott, Lei Shen, Richard D Hockett, John T Brandt, Joseph R Walker, Elliott M Antman, William L Macias, Eugene Braunwald,[...]. Circulation 2009
484
13

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).
Borja Ibanez, Stefan James, Stefan Agewall, Manuel J Antunes, Chiara Bucciarelli-Ducci, Héctor Bueno, Alida L P Caforio, Filippo Crea, John A Goudevenos, Sigrun Halvorsen,[...]. Eur Heart J 2018
12

Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study.
Jean-Philippe Collet, Jean-Sébastien Hulot, Anna Pena, Eric Villard, Jean-Baptiste Esteve, Johanne Silvain, Laurent Payot, Delphine Brugier, Guillaume Cayla, Farzin Beygui,[...]. Lancet 2009
697
12

Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation.
Nicoline J Breet, Jochem W van Werkum, Heleen J Bouman, Johannes C Kelder, Henk J T Ruven, Egbert T Bal, Vera H Deneer, Ankie M Harmsze, Jan A S van der Heyden, Benno J W M Rensing,[...]. JAMA 2010
638
12



Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite.
Miho Kazui, Yumi Nishiya, Tomoko Ishizuka, Katsunobu Hagihara, Nagy A Farid, Osamu Okazaki, Toshihiko Ikeda, Atsushi Kurihara. Drug Metab Dispos 2010
553
11

Clopidogrel Pharmacogenetics.
Naveen L Pereira, Charanjit S Rihal, Derek Y F So, Yves Rosenberg, Ryan J Lennon, Verghese Mathew, Shaun G Goodman, Richard M Weinshilboum, Liewei Wang, Linnea M Baudhuin,[...]. Circ Cardiovasc Interv 2019
47
23

Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention.
Larisa H Cavallari, Francesco Franchi, Fabiana Rollini, Latonya Been, Andrea Rivas, Malhar Agarwal, D Max Smith, Kimberly Newsom, Yan Gong, Amanda R Elsey,[...]. J Transl Med 2018
27
40

Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement.
Dirk Sibbing, Werner Koch, Daniela Gebhard, Tibor Schuster, Siegmund Braun, Julia Stegherr, Tanja Morath, Albert Schömig, Nicolas von Beckerath, Adnan Kastrati. Circulation 2010
416
11


Personalized antiplatelet therapy according to CYP2C19 genotype after percutaneous coronary intervention: a randomized control trial.
Xiang Xie, Yi-Tong Ma, Yi-Ning Yang, Xiao-Mei Li, Ying-Ying Zheng, Xiang Ma, Zhen-Yan Fu, Ba Bayinsilema, Yan Li, Zi-Xiang Yu,[...]. Int J Cardiol 2013
67
16

Clinical Value of CYP2C19 Genetic Testing for Guiding the Antiplatelet Therapy in a Chinese Population.
De-Liang Shen, Bo Wang, Jing Bai, Qing Han, Chuang Liu, Xiao-Hui Huang, Jin-Ying Zhang. J Cardiovasc Pharmacol 2016
43
23


Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC).
Kelly E Caudle, Henry M Dunnenberger, Robert R Freimuth, Josh F Peterson, Jonathan D Burlison, Michelle Whirl-Carrillo, Stuart A Scott, Heidi L Rehm, Marc S Williams, Teri E Klein,[...]. Genet Med 2017
226
10

Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium.
Roxana Mehran, Sunil V Rao, Deepak L Bhatt, C Michael Gibson, Adriano Caixeta, John Eikelboom, Sanjay Kaul, Stephen D Wiviott, Venu Menon, Eugenia Nikolsky,[...]. Circulation 2011
10

Effects of CYP2C19 genotype on outcomes of clopidogrel treatment.
Guillaume Paré, Shamir R Mehta, Salim Yusuf, Sonia S Anand, Stuart J Connolly, Jack Hirsh, Katy Simonsen, Deepak L Bhatt, Keith A A Fox, John W Eikelboom. N Engl J Med 2010
393
10

Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects.
Jean-Sébastien Hulot, Alessandra Bura, Eric Villard, Michel Azizi, Véronique Remones, Catherine Goyenvalle, Martine Aiach, Philippe Lechat, Pascale Gaussem. Blood 2006
681
10

2018 ESC/EACTS Guidelines on myocardial revascularization.
Franz-Josef Neumann, Miguel Sousa-Uva, Anders Ahlsson, Fernando Alfonso, Adrian P Banning, Umberto Benedetto, Robert A Byrne, Jean-Philippe Collet, Volkmar Falk, Stuart J Head,[...]. Eur Heart J 2019
10

Frequency and clinical outcomes of CYP2C19 genotype-guided escalation and de-escalation of antiplatelet therapy in a real-world clinical setting.
Jesse Martin, Alexis K Williams, Melissa D Klein, Vindhya B Sriramoju, Shivanshu Madan, Joseph S Rossi, Megan Clarke, Jonathan D Cicci, Larisa H Cavallari, Karen E Weck,[...]. Genet Med 2020
21
47

Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial.
Matthew J Price, Peter B Berger, Paul S Teirstein, Jean-François Tanguay, Dominick J Angiolillo, Douglas Spriggs, Sanjeev Puri, Mark Robbins, Kirk N Garratt, Olivier F Bertrand,[...]. JAMA 2011
962
10

Prospective CYP2C19 Genotyping to Guide Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Pragmatic Randomized Clinical Trial.
Sony Tuteja, Henry Glick, William Matthai, Irving Nachamkin, Ashwin Nathan, Karen Monono, Craig Carcuffe, Karen Maslowski, Gene Chang, Taisei Kobayashi,[...]. Circ Genom Precis Med 2020
16
62

Bedside monitoring to adjust antiplatelet therapy for coronary stenting.
Jean-Philippe Collet, Thomas Cuisset, Grégoire Rangé, Guillaume Cayla, Simon Elhadad, Christophe Pouillot, Patrick Henry, Pascal Motreff, Didier Carrié, Ziad Boueri,[...]. N Engl J Med 2012
636
10

Trends in Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After Percutaneous Coronary Intervention, 2008-2016.
Elias J Dayoub, Matthew Seigerman, Sony Tuteja, Taisei Kobayashi, Daniel M Kolansky, Jay Giri, Peter W Groeneveld. JAMA Intern Med 2018
49
18

International Expert Consensus on Switching Platelet P2Y12 Receptor-Inhibiting Therapies.
Dominick J Angiolillo, Fabiana Rollini, Robert F Storey, Deepak L Bhatt, Stefan James, David J Schneider, Dirk Sibbing, Derek Y F So, Dietmar Trenk, Dimitrios Alexopoulos,[...]. Circulation 2017
180
9

Role of genetic testing in patients undergoing percutaneous coronary intervention.
Jae Youn Moon, Francesco Franchi, Fabiana Rollini, Jose R Rivas Rios, Megha Kureti, Larisa H Cavallari, Dominick J Angiolillo. Expert Rev Clin Pharmacol 2018
43
20

Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel.
J T Brandt, S L Close, S J Iturria, C D Payne, N A Farid, C S Ernest, D R Lachno, D Salazar, K J Winters. J Thromb Haemost 2007
558
9

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update.
J A Johnson, K E Caudle, L Gong, M Whirl-Carrillo, C M Stein, S A Scott, M T Lee, B F Gage, S E Kimmel, M A Perera,[...]. Clin Pharmacol Ther 2017
255
9

Results of genotype-guided antiplatelet therapy in patients who undergone percutaneous coronary intervention with stent.
Jesús Sánchez-Ramos, Cristina Lucía Dávila-Fajardo, Pablo Toledo Frías, Xando Díaz Villamarín, Luis Javier Martínez-González, Susana Martínez Huertas, Francisco Burillo Gómez, Juan Caballero Borrego, Alicia Bautista Pavés, Mª Carmen Marín Guzmán,[...]. Int J Cardiol 2016
33
27

Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised controlled superiority trial.
Guillaume Cayla, Thomas Cuisset, Johanne Silvain, Florence Leclercq, Stephane Manzo-Silberman, Christophe Saint-Etienne, Nicolas Delarche, Anne Bellemain-Appaix, Grégoire Range, Rami El Mahmoud,[...]. Lancet 2016
197
9

Association Between CYP2C19 Loss-of-Function Allele Status and Efficacy of Clopidogrel for Risk Reduction Among Patients With Minor Stroke or Transient Ischemic Attack.
Yilong Wang, Xingquan Zhao, Jinxi Lin, Hao Li, S Claiborne Johnston, Yi Lin, Yuesong Pan, Liping Liu, David Wang, Chunxue Wang,[...]. JAMA 2016
173
9

CYP2C19 pharmacogenetics versus standard of care dosing for selecting antiplatelet therapy in patients with coronary artery disease: A meta-analysis of randomized clinical trials.
Babikir Kheiri, Mohammed Osman, Ahmed Abdalla, Tarek Haykal, Pranay V Pandrangi, Adam Chahine, Sahar Ahmed, Khansa Osman, Ghassan Bachuwa, Mustafa Hassan,[...]. Catheter Cardiovasc Interv 2019
19
42


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.